MedTrace Logo

Network-Guided Individualized TMS for BPSD in Alzheimer's Disease: A Double-blind Randomized Controlled Trial

NCT07692542 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-07-09

No results posted yet for this study

Summary

Evaluate the safety and efficacy of personalized network-guided transcranial magnetic stimulation for treating behavioral and psychological symptoms in patients with Alzheimer's disease.

Conditions

  • Transcranial Magnetic Stimulation
  • Behavioral and Psychological Symptoms in Alzheimer's Disease
  • Individualized Navigation

Interventions

OTHER

transcranial magnetic stimulation

Neuronavigated Theta-Burst Transcranial Magnetic Stimulation Other Name:

OTHER

transcranial magnetic stimulation

Neuronavigated Theta-Burst Transcranial Magnetic Stimulation Other Name:

Sponsors & Collaborators

  • Anhui Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2026-12-31
Completion
2027-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07692542 on ClinicalTrials.gov